ÐÓ°ÉÔ­´´

Denali Therapeutics logo

Denali Therapeutics

Denali Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of therapies for patients who are suffering from neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, ALS, and more.

1

Funding Rounds

$130.0m

Money raised

Overview

Denali Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of therapies for patients who are suffering from neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, ALS, and more.
  • Website:
  • Social accounts:

Funding series

Funding Series Analysis

The company Denali Therapeutics has raised a total of $130m in funding over 1 rounds.

Key Insights:

  • Denali Therapeutics Series B round, August 2016: $130m
Denali Therapeutics logo
Denali Therapeutics Series B round, August 2016 $130m